Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1984 1
1985 2
1986 3
1987 3
1988 3
1990 2
1991 3
1992 3
1993 4
1994 1
1996 6
1997 3
1998 5
1999 2
2000 9
2001 9
2002 7
2003 6
2004 7
2005 4
2006 7
2007 7
2008 11
2009 8
2010 13
2011 19
2012 19
2013 19
2014 28
2015 19
2016 29
2017 35
2018 33
2019 34
2020 26
2021 36
2022 29
2023 25
2024 26
2025 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

460 results

Results by year

Filters applied: . Clear all
Page 1
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis.
Rocco JM, Oved JH, Patel RJ, Herskovits AZ, Nair N, Shakoory B, Robertson T, Dileo R, Jacobs MW, Zerbe C, Gordon R, Ombrello MJ, Ombrello AK, Shah NN, Dimitrova D, Kanakry JA, Zelenetz AD, Moskowitz AJ, Stuver RN, Epstein-Peterson ZD, Ghione P, Mead E, Shahid Z, Giralt SA, Raj SS, Park JH, Maillard I, Geyer MB, Xiao W, Dogan A, Lim MS, Zwicker JI, Mones JV, Parameswaran R, Banaszak LG, Geller S, Santomasso BD, Shouval R, Curran KJ, Delmonte OM, Notarangelo LD, Cohen JI, Holland SM, Salles GA, Horwitz SM, Vardhana SA, Perales MA, Schwartz D, Sereti I, Johnson WT. Rocco JM, et al. Among authors: horwitz sm. Blood. 2025 Dec 10:blood.2025030976. doi: 10.1182/blood.2025030976. Online ahead of print. Blood. 2025. PMID: 41369611
Skin Response to Mogamulizumab in Patients With Mycosis Fungoides and Sezary Syndrome: A Retrospective, Real World Cohort.
Christensen RE, Stuver R, Dusza S, Epstein-Peterson ZD, Ghione P, Horwitz SM, Johnson W, Moskowitz AJ, Myskowski P, Pulitzer M, Geller S. Christensen RE, et al. Among authors: horwitz sm. Clin Lymphoma Myeloma Leuk. 2025 Dec;25(12):e1098-e1107.e3. doi: 10.1016/j.clml.2025.08.008. Epub 2025 Aug 18. Clin Lymphoma Myeloma Leuk. 2025. PMID: 40930938
Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era.
Cassanello G, Drill E, Qiu A, Ewalt MD, Hamlin P, Horwitz SM, Joffe E, Kumar A, Moskowitz AJ, Noy A, Owens C, Palomba ML, Zelenetz AD, Dogan A, Busam KJ, Yahalom J, Salles G, Matasar MJ, Falchi L. Cassanello G, et al. Among authors: horwitz sm. Blood Cancer J. 2025 Aug 29;15(1):150. doi: 10.1038/s41408-025-01354-1. Blood Cancer J. 2025. PMID: 40883287 Free PMC article. No abstract available.
Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma.
Iyer S, Mehta-Shah N, Advani R, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Alpdogan O, Feldman TA, Camus V, Gritti G, Zinzani PL, Belada D, Mayer J, Choi I, Cheong JW, Rustia E, Fenton K, Fanale M, Savage KJ, Horwitz SM. Iyer S, et al. Among authors: horwitz sm. Blood Adv. 2025 Dec 9;9(23):5976-5987. doi: 10.1182/bloodadvances.2024015282. Blood Adv. 2025. PMID: 40829107 Free PMC article. Clinical Trial.
Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: insights from a retrospective analysis.
Luttwak E, Robin ET, Drill E, Boardman A, Caron P, Epstein-Peterson Z, Falchi L, Ghione P, Hamlin PA, Horwitz SM, Intlekofer AM, Johnson W, Kumar A, Lue J, Noy A, Owens C, Palomba ML, Steiner R, Stuver R, Torka P, Vardhana S, Zelenetz AD, Salles G, Moskowitz CH, Moskowitz AJ. Luttwak E, et al. Among authors: horwitz sm. Leuk Lymphoma. 2025 Jul;66(7):1276-1283. doi: 10.1080/10428194.2025.2465553. Epub 2025 Mar 1. Leuk Lymphoma. 2025. PMID: 40598813
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma.
Bouska A, Zhang W, Sharma S, Holte H, Shah RA, Lone WG, Soma MA, Yang R, Liu X, Mehmood S, Chawla RS, Cappelli LV, Fiore D, Gong Q, Heavican-Foral TB, Cannatella JJ, Amador C, Arif A, Smith LM, Lim ST, Ong CK, Feldman AL, Du MQ, Perry AM, de Leval L, Greiner TC, Fu K, Trøen G, Vodák D, Nakken S, Delabie J, Weinstock D, Pileri S, Laginestra A, Kim K, Pajvani U, Vose JM, Weisenburger DD, Horwitz SM, Dave S, Khoury J, Inghirami G, Chan WC, Iqbal J. Bouska A, et al. Among authors: horwitz sm. Am J Hematol. 2025 Sep;100(9):1486-1501. doi: 10.1002/ajh.27736. Epub 2025 Jun 13. Am J Hematol. 2025. PMID: 40510016 Free PMC article.
Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma.
Khan N, Dahi PB, Khimani F, Shustov AR, Shadman M, Ruan J, Moskowitz AJ, Zelenetz AD, Noy A, Straus DJ, Drullinsky P, Hamilton A, Kumar A, Sauter CS, Shah GL, Matasar MJ, Drill E, Davey T, Hancock H, Ganesan N, Galasso N, van Beisen K, Giralt S, Horwitz SM. Khan N, et al. Among authors: horwitz sm. Blood Adv. 2025 Sep 23;9(18):4687-4692. doi: 10.1182/bloodadvances.2024014263. Blood Adv. 2025. PMID: 40179392 Free PMC article. Clinical Trial.
State-dependent motion of a genetically encoded fluorescent biosensor.
Rosen PC, Horwitz SM, Brooks DJ, Kim E, Ambarian JA, Waidmann L, Davis KM, Yellen G. Rosen PC, et al. Among authors: horwitz sm. Proc Natl Acad Sci U S A. 2025 Mar 11;122(10):e2426324122. doi: 10.1073/pnas.2426324122. Epub 2025 Mar 6. Proc Natl Acad Sci U S A. 2025. PMID: 40048274 Free PMC article.
460 results